Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration

European Journal of Pharmacology

Volumn 377, Issue 1, 1999, Pages 13-19

  Malinowska, Barbara ^a   Napiórkowska Pawlak, Dorota ^a   Pawlak, Robert ^a   Buczko, Włodzimierz ^a   Göthert, Manfred ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

5 HT3 receptor; Behavioral sleep; Ethanol; Ethanol withdrawal; Ifenprodil; NMDA receptor

Indexed keywords

ALCOHOL; ALPHA 1 ADRENERGIC RECEPTOR; DIZOCILPINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ONDANSETRON; SEROTONIN 3 RECEPTOR;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SLEEP TIME;

EID: 0344417904     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00393-3     Document Type: Article

References (40)

1. 14C -guanidinium influx in N1E-115 neuroblastoma cells Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;149-156.
2. 3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;145-152.
3. A and NMDA receptor antagonists on ethanol-induced behavioral sleep in rats. Alcohol. 14:1997;167-173.
4. Blevins T., Mirshahi T., Woodward J.J. Increased agonist and antagonist sensitivity of N-methyl-D-aspartate stimulated calcium flux in cultured neurons following chronic ethanol exposure. Neurosci. Lett. 200:1995;214-218.
5. Buczko W., Malinowska B., Pawlak D.G., Pawlak R., Göthert M. Ifenprodil influences changes in mice behaviour related to acute and chronic ethanol administration. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;R186. Suppl. 1.
6. Carter C., Rivy J.P., Scatton B. Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor. Eur. J. Pharmacol. 164:1989;611-612.
7. Chandler L.J., Newsom H., Sumners C., Crews F. Chronic ethanol exposure potentiates NMDA excitoxicity in cerebral cortical neurons. J. Neurochem. 60:1993;1578-1581.
8. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Onaivi E.S., Tyers M.B. Ondansetron inhibits a behavioural consequences of withdrawing from drugs of abuse. Pharmacol. Biochem. Behav. 36:1990;339-344.
9. Daniell L.C. Alternation of general anesthetic potency by agonists and antagonists of the polyamine binding site of the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 261:1992;304-310.
10. Danysz W., Dyr W., Jankowska E., Kostowski W. The involvement of NMDA receptors in acute and chronic effects of ethanol. Alcohol. Clin. Exp. Res. 16:1992;499-504.
11. Engblom A.C., Courtney M.J., Kukkonen J.P., Akerman K.E.O. Ethanol specifically inhibits NMDA receptors with affinity for ifenprodil in the low micromolar range in cultured cerebellar granule cells. J. Neurochem. 69:1997;2162-2168.
12. Fink K., Göthert M. Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;312-319.
13. Ginski M.J., Witkin J.M. Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists. Psychopharmacology. 114:1994;573-582.
14. Gotti B., Duverger D., Bertin J., Carter C., Dupont R., Frost J., Gaudilliere B., MacKenzie E.T., Rousseau J., Scatton B., Wick A. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents: I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmacol. Exp. Ther. 247:1988;1211-1221.
15. Göthert M., Fink K. Inhibition of N-methyl-D-aspartate- and L-glutamate-induced noradrenaline and acetylcholine release in the rat brain by ethanol. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;516-521.
16. Grant K.A., Valverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizure and the NMDA receptor complex. Eur. J. Pharmacol. 176:1990;286-296.
17. 3 antagonist MDL 72222 exacerbates ethanol withdrawal seizures in mice. Alcohol. Clin. Exp. Res. 18:1994;410-414.
18. Hoffman P.L., Tabakoff B. Alcohol dependence: a commentary on mechanisms. Alcohol Alcohol. 31:1996;333-340.
19. Hoffman P.L., Rabe C.S., Moses F., Tabakoff B. N-Methyl-D-aspartate and ethanol: inhibition of calcium flux and cyclic GMP production. J. Neurochem. 52:1989;1937-1940.
20. Iorio K.R., Tabakoff B., Hoffman P.L. Glutamate-induced neurotoxicity is increased in cerebellar granule cells exposed chronically to ethanol. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect. 248:1993;209-212.
21. 3 receptors and central effects of ethanol. Pol. J. Pharmacol. 48:1996;243-254.
22. 3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol. 10:1993;369-373.
23. Kotlinska J., Liljequist S. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures. Psychopharmacology. 127:1996;238-244.
24. Liljequist S. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. Eur. J. Pharmacol. 192:1991;197-198.
25. Lovinger D.M. Developmental decrease in ethanol inhibition of N-methyl-D-aspartate receptors in rat neocortical neurons: relation to the action of ifenprodil. J. Pharmacol. Exp. Ther. 274:1995;164-172.
26. Lovinger D.M. Alcohols and neurotransmitter gated ion channels: past, present and future. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;267-282.
27. 3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol. Pharmacol. 40:1991;263-270.
28. Lovinger D.M., White G., Weight F.F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 243:1989;1721-1724.
29. Malinowska B., Pawlak D.G., Godlewski G., Buczko W., Göthert M. Ifenprodil influences ethanol-related behaviour in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;R56.
30. 3 receptor. Neuropharmacology. 34:1995;621-629.
31. 3 receptor stimulation. Pharmacol. Biochem. Behav. 45:1993;755-757.
32. 2 binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;245-252.
33. Murata S., Kawasaki K. Common and uncommon behavioral effects of antagonists for different modulatory sites in the NMDA receptor/channel complex. Eur. J. Pharmacol. 239:1993;9-15.
34. Ritzmann R.F., Tabakoff B. Body temperature in mice: a quantitative measure of alcohol tolerance and physical dependence. J. Pharmacol. Exp. Ther. 199:1976;158-170.
35. 3 receptors in the CNS. Springer-Verlag, Berlin, Heidelberg, pp. 587-612.
36. Simson P.E., Criswell H.E., Johnson K.E., Hicks R.E., Breese G.R. Ethanol inhibits NMDA-evoked electrophysiological activity in vivo. J. Pharmacol. Exp. Ther. 257:1991;225-231.
37. Tsuda M., Suzuki T., Misawa M. Age-related decrease in the antiseizure effect of ifenprodil against pentylenetetrazole in mice. Dev. Brain Res. 104:1997;201-204.
38. Tsuda M., Shimizu N., Yajima Y., Suzuki Y., Misawa M. Hypersusceptibility to DMCM-induced seizures during diazepam withdrawal in mice: evidence for upregulation of NMDA receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;309-315.
39. Yang X., Criswell H.E., Simson P., Moy S., Bresse G.R. Evidence for a selective effect of ethanol on N-methyl-D-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitive N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 278:1996;114-124.
40. Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44:1993;851-859.